Venezuela is one of the emerging pharmaceutical markets in South America, but economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers, according to a new GlobalData report.
CountryFocus: Healthcare, Regulatory and ReimburseOriginal Article
